Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pasireotide in the Personalized Treatment of Acromegaly
Manel Puig‐Domingo, Ignacio Bernabéu, Antonio Picó, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Acromegaly: pathogenesis, diagnosis, and management
Maria Fleseriu, Fabienne Langlois, Dawn Shao Ting Lim, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 11, pp. 804-826
Closed Access | Times Cited: 133
Pasireotide—a novel somatostatin receptor ligand after 20 years of use
Marek Bolanowski, Marcin Kałużny, Przemysław Witek, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 3, pp. 601-620
Open Access | Times Cited: 39
Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts’ consensus statement
Sylvère Störmann, Sebastian M. Meyhöfer, Jan B. Groener, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9
Differential Impact of Medical Therapies for Acromegaly on Glucose Metabolism
Federico Gatto, Anna Arecco, Jessica Amarù, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 465-465
Open Access | Times Cited: 1
Personalized Medical Treatment of Patients With Acromegaly: A Review
Dawn Shao Ting Lim, Maria Fleseriu
Endocrine Practice (2022) Vol. 28, Iss. 3, pp. 321-332
Closed Access | Times Cited: 24
Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing’s disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study
Ulla Feldt‐Rasmussen, Marek Bolanowski, Shao‐Ling Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Personalized Medicine in Acromegaly: The ACROFAST Study
Montserrat Marqués-Pamies, Joan Gil, Miguel Sampedro‐Núñez, et al.
The Journal of Clinical Endocrinology & Metabolism (2024)
Open Access | Times Cited: 4
Molecular Chimera in Cancer Drug Discovery: Beyond Antibody Therapy, Designing Grafted Stable Peptides Targeting Cancer
Arpan Chowdhury, Prajesh Shrestha, Seetharama D. Jois
International Journal of Peptide Research and Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Pasireotide as first line medical therapy for selected patients with acromegaly
Nicoleta Cristina Olarescu, Anders Palmstrøm Jørgensen, Shahriar Atai, et al.
Pituitary (2025) Vol. 28, Iss. 3
Open Access
Clinical Implications of Molecular and Genetic Biomarkers in Cushing’s Disease: A Literature Review
Laura Chinezu, Maximilian Cosma Gliga, Mihnea Bogdan Borz, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 9, pp. 3000-3000
Open Access
Data mining analyses for precision medicine in acromegaly: a proof of concept
Joan Gil, Montserrat Marqués-Pamies, Miguel Sampedro, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly
Sabina Ruiz, Joan Gil, Betina Biagetti, et al.
Clinical Endocrinology (2023) Vol. 99, Iss. 4, pp. 378-385
Open Access | Times Cited: 10
Efficacy of pasireotide LAR for acromegaly: a prolonged real-world monocentric study
Vittoria Favero, Benedetta Zampetti, Emanuela Carioni, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Predictors of biochemical response to somatostatin receptor ligands in acromegaly
Mónica Marazuela, Rebeca Martínez‐Hernández, Montserrat Marqués-Pamies, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2024) Vol. 38, Iss. 4, pp. 101893-101893
Open Access | Times Cited: 3
Insights from an Italian Delphi panel: exploring resistance to first-generation somatostatin receptor ligands and guiding second-line medical therapies in acromegaly management
Silvia Grottoli, Pietro Maffei, Alberto Tresoldi, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 12, pp. 2999-3017
Open Access | Times Cited: 3
Second line treatment of acromegaly: Pasireotide or Pegvisomant?
Sabrina Chiloiro, Antonio Bianchi, Antonella Giampietro, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 36, Iss. 6, pp. 101684-101684
Closed Access | Times Cited: 16
Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
Antonio Bianchi, Sabrina Chiloiro, Antonella Giampietro, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8
Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
Agnieszka Tomasik, Maria Stelmachowska‐Banaś, Maria Maksymowicz, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 14
Immunohistochemical evaluation of biomarkers with predictive role in acromegaly: a literature review
Maximilian Cosma Gliga, Ligia Gabriela Tătăranu, Mihaela Popescu, et al.
Romanian Journal of Morphology and Embryology (2023) Vol. 64, Iss. 1, pp. 25-33
Open Access | Times Cited: 7
Successful medical management of a pituitary macroadenoma with features of resistant acromegaly and hyperprolactinemia using pasireotide
Khaled Baagar, Amna Sadiq, Adeel Ahmad Khan, et al.
Qatar medical journal (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Long-term pasireotide-LAR treatment in the personalized therapy of patients with complex acromegaly: a collection of clinical experiences
Sabrina Chiloiro, Marialuisa Appetecchia, Antonio Bianchi, et al.
Drugs in Context (2024) Vol. 13, pp. 1-9
Open Access | Times Cited: 2
Rapid Resolution of Recalcitrant Headache With Pasireotide in an Adult Patient With Acromegaly
Zeinab Dabbous, Zaina Rohani, Abeer Abdalrubb, et al.
JCEM Case Reports (2024) Vol. 2, Iss. 8
Open Access | Times Cited: 2
Innovative therapeutics in acromegaly
Leandro Kasuki, Mônica R. Gadelha
Best Practice & Research Clinical Endocrinology & Metabolism (2022) Vol. 36, Iss. 6, pp. 101679-101679
Closed Access | Times Cited: 9
Resistance of neuroendocrine tumours to somatostatin analogs
Anna Angelousi, Anna Koumarianou, Eleftherios Chatzellis, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 1, pp. 33-52
Closed Access | Times Cited: 4
Delving into Acromegaly
Sylvère Störmann, Katharina Schilbach
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1654-1654
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top